Abstract: Use of rylene derivatives I with the following definition of the variables: X together both —COOM; Y a radical -L-NR1R2??(y1) -L-Z—R3??(y2) the other radical hydrogen; together both hydrogen; R is optionally substituted (het)aryloxy, (het)arylthio; P is —NR1R2; B is alkylene; optionally substituted phenylene; combinations thereof; A is —COOM; —SO3M; —PO3M2; D is optionally substituted phenylene, naphthylene, pyridylene; M is hydrogen; alkali metal cation; [NR5]4+; L is a chemical bond; optionally indirectly bonded, optionally substituted (het)arylene radical; R1, R2 are optionally substituted (cyclo)alkyl, (het)aryl; together optionally substituted ring comprising the nitrogen atom; Z is —O—; —S—; R3 is optionally substituted alkyl, (het)aryl; R? is hydrogen; optionally substituted (cyclo)alkyl, (het)aryl; R5 is hydrogen; optionally substituted alkyl (het)aryl; m is 0, 1, 2; n, p m=0: 0, 2, 4 where: n+p=2, 4, if appropriate 0; m=1: 0, 2, 4 where: n+p=0, 2, 4; m=2: 0, 4, 6

Abstract: A photovoltaic device (10) having a coaxial molecular stack (12) for transferring photocurrent is disclosed. The device (10) comprises a plurality of coaxial molecular stacks (12) located between and oriented substantially perpendicular to first (14) and second (16) electrodes to provide charge transport of photocurrent through each coaxial molecular stack (12) in the photovoltaic device (10). Each coaxial molecular stack (12) comprises a plurality of ?-conjugated planar supramolecules (18) stackable through columnar self assembly to form the coaxial molecular stack (12). Each supramolecule (18) is comprised of a ?-conjugated hub (20) covalently appended to multiple copies of an electron acceptor spoke (22) to form an outer n-channel with a coaxial inner p-channel.

Abstract: Disclosed are compounds according to formula (I): wherein A, Q, X, Y, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as defined herein. The disclosure also relates to pharmaceutical compositions containing a compound of formula (I), to processes for preparing the compounds of formula (I), and to methods of using the compounds of formula (I).

Abstract: A star-shaped oligothiophene-arylene derivative in which an oligothiophene having p-type semiconductor characteristics is bonded to an arylene having n-type semiconductor characteristics positioned in the central moiety of the molecule and forms a star shape with the arylene, thereby simultaneously exhibiting both p-type and n-type semiconductor characteristics. Further, an organic thin film transistor using the oligothiophene-arylene derivative. The star-shaped oligothiophene-arylene derivative can be spin-coated at room temperature, leading to the fabrication of organic thin film transistors simultaneously satisfying the requirements of high charge carrier mobility and low off-state leakage current.

Abstract: Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

Abstract: The invention concerns a compound of the Formula (I), wherein Qa is heteroaryl and is substituted with halogeno; R1 and R2 are each hydrogen; and Qb is phenyl or heteroaryl, and Qb may optionally bear 1 or 2 substituents selected from hydroxy, halogeno and (1-6C)alkyl, or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.

Abstract: Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

Abstract: Use of rylene derivatives I with the following definition of the variables: X together both —COOM; Y a radical -L-NR1R2 ??(y1) -L-Z-R3 ??(y2) the other radical hydrogen; together both hydrogen; R is optionally substituted (het)aryloxy, (het)arylthio; P is —NR1R2; B is alkylene; optionally substituted phenylene; combinations thereof; A is —COOM; —SO3M; —PO3M2; D is optionally substituted phenylene, naphthylene, pyridylene; M is hydrogen; alkali metal cation; [NR5]4+; L is a chemical bond; optionally indirectly bonded, optionally substituted (het)arylene radical; R1, R2 are optionally substituted (cyclo)alkyl, (het)aryl; together optionally substituted ring comprising the nitrogen atom; Z is —O—; —S—; R3 is optionally substituted alkyl, (het)aryl; R? is hydrogen; optionally substituted (cyclo)alkyl, (het)aryl; R5 is hydrogen; optionally substituted alkyl (het)aryl; m is 0, 1, 2; n, p m=0: 0, 2, 4 where: n+p=2, 4, if appropriate 0; m=1: 0, 2, 4 where: n+p=0, 2, 4; m=2: 0, 4,

Abstract: This invention relates to process for preparing fluorinated dyes selected from the group consisting of compounds of the general formulae (I) and (III) and mixtures thereof by reacting the corresponding compounds which do not have R12 or R30 as substituents with compounds of the general formula R12A or R30A where A is selected from the group consisting of I and Br, the compounds obtained from said process and the use of these fluorinated dyes in electrophoretic displays.

Abstract: Anisotropic films based on sulfoderivatives of perylenetetracarboxylic acid dibenzimidazole (PTCA DBI) which contain oxo groups pendant to a perylene core. The oxo-groups, in combination with portions of the perylene core, form a quinoid system of bonds. The oxo substituted PTCA DBI sulfoderivatives form liquid crystal systems possessing high optical properties. Said liquid crystal systems can be applied onto various substrates to obtain optically isotropic or anisotropic, at least partially crystalline, films applicable in various fields.

Abstract: This invention relates to new fluorescent or non-fluorescent dye compounds having a terminal hydroxy, carboxylic acid/ester or amino group and a process for their preparation. The new fluorescent or non-fluorescent dye compounds are useful as colorants for preparing colored synthetic polymer resins with pigmentary properties, for dyeing or printing homo- or mixed synthetic, semi-synthetic or natural polymers or substrates or for preparing inks. The dye compounds provide excellent properties, especially high temperature stability and easy applicability.

Abstract: The present invention relates to indole derivatives represented by the following compound 1 and the pharmacologically acceptable acid addition salt thereof. ##STR1## The compounds of the present invention were found to exhibit strong antitussive and analgesic actions as a result of pharmacological evaluation, and can be used in the pharmaceutical field as effective antitussives and analgesics.

Abstract: A dichroic dye for coloring liquid crystal compositions are disclosed which is represented by the following general formula: ##STR1## in which Dye 1 and Dye 2 each represents a group of atoms necessary to form a linear dye structure containing an azo, azomethine or ester group; X represents a halogen atom; and n represents an integer of from 1 to 10. The dye is suited for use in color liquid crystal display devices, e.g., of guest-host type.

Abstract: Compounds of the formula ##STR1## wherein X denotes a chlorine or bromine atom, n denotes a number from zero to 4 and Y denotes an oxygen atom or a nitrogen atom, and A, if Y represents an oxygen atom, is the phenyl radical, which can be substituted by substituents from the group comprising halogen, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy, carbalkoxy with 1-4 carbon atoms in the alkyl radical, hydroxyl, carboxyl, CF.sub.3, nitro, phenoxy, phenoxy which is substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy and/or halogen, phenylamino, phenylamino which is substituted in the phenyl radical by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy and/or halogen, phenylazo and phenylazo which is substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -akloxy and/or halogen, or is the pyridyl radical, which can be substituted by halogen and/or C.sub.1 -C.sub.

Abstract: 1,1'-Binaphthyl-4,4',5,5',8,8'-hexacarboxylic acid compounds having the following formula: ##STR1## wherein R.sub.1 is hydrogen, halogen, or alkyl; when X is oxygen, Y is hydrogen, alkyl, a cycloalkyl, or an aryl containing at least one substituent from the group including: halogen, alkyl, or alkoxy, when X is nitrogen, Y is ##STR2## wherein R.sub.2 is hydrogen, halogen, or alkyl; Y being linked to X with the formation of a benzimidazole cycle.The method for preparing the compounds according to the present invention resides in the treatment of that 1,1'-binaphthyl-4,4',5,5',8,8'-hexacarboxylic acid anhydride with an alkali to give a corresponding salt which is condensed with orthophenylenediamines upon heating at reflux at a pH of from 6.3 to 6.8. The resulting benzimidazole-1,1'-binaphthyl-4,4',5,5',8,8'-hexacarboxylic acid anhydride having the formula: ##STR3## wherein R.sub.

Abstract: Electrically conductive organic perylene derivatives and their use. They have the formulae ##STR1## where R is hydrogen, alkyl or oxaalkyl of 1 to 10 carbon atoms, cycloalkyl, alkaryl or aryl which is unsubstituted or substituted by from 1 to 3 alkoxy, halogen, nitro or amino, or is hydroxyalkyl-CH.sub.2 -(CH.sub.2).sub.n -OH, where n is an integer from 1 to 10, and which may or may not contain oxa groups, and R.sub.1 is one of the following divalent radicals which join the two N atoms to form a ring: ##STR2## The compounds may be used for the manufacture of electrically conductive systems and of semiconductors.